The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (8)
- Psilocybin 2026-10-06 · Expand citations
- Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis 2026-06-15 · Expand citations
- Music and non-music approaches in psilocybin-assisted psychotherapy: The sound of silence 2025-05-15 · Expand citations
- Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional properties 2024-10-14 · Expand citations
- Does psilocybin reduce symptoms of depression in adults with major depressive disorder or life-threatening cancer? 2024-10-09 · Expand citations
- Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training 2023-09-08 · Expand citations
- Imprinting: expanding the extra-pharmacological model of psychedelic drug action to incorporate delayed influences of sets and settings 2023-07-17 · Expand citations
- A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness 2023-01-01 · Expand citations